
Zhongchao ZCMD
$ 0.56
5.9%
Annual report 2024
added 01-03-2026
Zhongchao Total Assets 2011-2026 | ZCMD
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Zhongchao
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.9 M | 24.4 M | 38.6 M | 36.3 M | 34.8 M | 17.7 M | 14 M | 6.98 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.6 M | 6.98 M | 24.8 M |
Quarterly Total Assets Zhongchao
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 36.3 M | - | 36.8 M | - | 34.8 M | - | - | - | 17.7 M | - | - | - | 14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.8 M | 14 M | 27.9 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | ||
|
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M | ||
|
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | ||
|
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | ||
|
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | ||
|
Evolent Health
EVH
|
1.82 B | $ 4.18 | 0.6 % | $ 392 M | ||
|
Health Catalyst
HCAT
|
859 M | $ 2.46 | 0.41 % | $ 148 M | ||
|
HealthStream
HSTM
|
511 M | $ 22.12 | -0.83 % | $ 672 M | ||
|
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | ||
|
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
3.16 B | $ 94.6 | -3.97 % | $ 8.09 B | ||
|
American Well Corporation
AMWL
|
436 M | $ 5.11 | -1.16 % | $ 76.6 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
71.6 M | - | -0.58 % | $ 51.7 M | ||
|
So-Young International
SY
|
2.74 B | $ 2.64 | 0.96 % | $ 210 M | ||
|
GoodRx Holdings
GDRX
|
1.39 B | $ 2.8 | 0.18 % | $ 1.08 B | ||
|
OptimizeRx Corporation
OPRX
|
183 M | $ 13.05 | -2.36 % | $ 223 M | ||
|
Omnicell
OMCL
|
2.12 B | $ 51.16 | 1.13 % | $ 2.36 B | ||
|
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | ||
|
Progyny
PGNY
|
607 M | $ 27.18 | -0.91 % | $ 2.33 B | ||
|
Phreesia
PHR
|
370 M | $ 17.33 | 2.54 % | $ 946 M | ||
|
Premier
PINC
|
3.1 B | $ 28.26 | - | $ 2.33 B | ||
|
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | ||
|
Schrödinger
SDGR
|
823 M | $ 18.34 | -1.48 % | $ 1.33 B | ||
|
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | ||
|
10x Genomics
TXG
|
965 M | $ 20.58 | 6.66 % | $ 2.41 B | ||
|
Teladoc Health
TDOC
|
3.52 B | $ 7.44 | -2.3 % | $ 1.27 B | ||
|
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
5.91 B | $ 241.36 | 0.08 % | $ 38.7 B | ||
|
SCWorx Corp.
WORX
|
6.35 M | $ 0.2 | 0.1 % | $ 292 K |